Grifols (GIFLF) Change in Taxes (2010 - 2025)
Grifols' (GIFLF) quarterly Change in Taxes came in at -$196.7 million in Q4 2025, down 4.6% on a YoY basis from -$206.2 million in Q4 2024, and down 4.6% quarter-over-quarter from -$188.1 million in Q4 2024.
Analysis
Grifols (GIFLF) Change in Taxes (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Change in Taxes for 11 consecutive years, with -$196.7 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Taxes fell 4.6% year-over-year to -$196.7 million; the trailing twelve-month figure through Dec 2025 stood at -$756.3 million (changed 0.25% YoY), and the FY2025 full-year result was -$190.9 million, down 1.52% from the prior year.
- Change in Taxes fell to -$196.7 million in Q4 2025 per GIFLF's latest filing, from -$188.1 million in the prior quarter.
- Across five years, Change in Taxes topped out at -$171.1 million in Q4 2023 and bottomed at -$200.4 million in Q4 2022.
- Historically, Change in Taxes has averaged -$189.1 million across 4 years, with a median of -$192.4 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Change in Taxes advanced 14.64% in 2023, then declined 9.94% in 2024.
- Over 4 years, Change in Taxes stood at -$200.4 million in 2022, then rose by 14.64% to -$171.1 million in 2023, then declined by 9.94% to -$188.1 million in 2024, then dropped by 4.6% to -$196.7 million in 2025.
- According to Business Quant data, Change in Taxes over the past three periods registered -$196.7 million, -$188.1 million, and -$171.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -131.00 Mn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 171.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 13.80 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -10.18 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -196.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -196.72 Mn |
| Dec 31, 2024 | -188.07 Mn |
| Dec 31, 2023 | -171.07 Mn |
| Dec 31, 2022 | -200.41 Mn |
| Sep 30, 2016 | -194.84 Mn |
| Sep 30, 2015 | 81.12 Mn |
| Sep 30, 2014 | 45.52 Mn |
| Jun 30, 2014 | -16.34 Mn |
| Mar 31, 2014 | 16.35 Mn |
| Sep 30, 2013 | 59.52 Mn |
| Jun 30, 2013 | 75.51 Mn |
| Mar 31, 2013 | 5.74 Mn |
| Dec 31, 2012 | -135.34 Mn |
| Sep 30, 2012 | 27.44 Mn |
| Jun 30, 2012 | 31.30 Mn |
| Mar 31, 2012 | -3.27 Mn |
| Dec 31, 2011 | 10.87 Mn |
| Sep 30, 2011 | 13.48 Mn |
| Dec 31, 2010 | -15.59 Mn |
| Sep 30, 2010 | -3.12 Mn |